Leeds STV
Image default

The Oxford Vaccine submitted for approval

The British Pharmaceutical AstraZeneca, together with the University of Oxford, submitted all data on their vaccine to the British medicine watchdog MHRA for approval. Earlier this month, the vaccines from the American companies Pfizer and Moderna came on the market.

The British pharmaceutical company AstraZeneca, which has developed a vaccine together with the University of Oxford, says that the vaccine can also prevent people from becoming ill from the mutated virus recently found in the United Kingdom.

This would be shown by studies carried out by the company. According to AstraZeneca, the changes in the genetic code of this new viral strain are not able to alter the structure of the protein and thus the vaccine also works with the mutated virus.

In October the Netherlands and other European countries ordered 300 million doses from AstraZeneca. They will actually be taken once the vaccine has been proven. The European Commission has made similar deals with five other manufacturers.

Related posts

NHS works closely with e-health providers to optimize the flow

Mary Johnson

Chinese social media giant TikTok scraps plans to build a global office in the UK, creating 3,000 jobs after Boris Johnson banned Huawei from UK 5G

Paolo Sorbello

Michael Owen gives his opinion on how Leeds United will play against Liverpool on opening day

Paolo Sorbello

Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.

This site uses Akismet to reduce spam. Learn how your comment data is processed.